63. 特発性血小板減少性紫斑病
[臨床試験数:311,薬物数:185(DrugBank:39),標的遺伝子数:43,標的パスウェイ数:132

Searched query = "Idiopathic thrombocytopenic purpura", "Primary immune thrombocytopenia"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00107913
(ClinicalTrials.gov)
September 200111/4/2005Study of Doxil in the Treatment of Patients With Refractory Idiopathic Thrombocytopenic PurpuraPhase II Study of Doxil in the Treatment of Patients With Refractory Idiopathic Thrombocytopenic PurpuraAutoimmune Thrombocytopenic PurpuraDrug: DoxilHematology and Oncology SpecialistsNULLRecruitingN/AN/ABoth10Phase 2United States